Luke Gammon

1.5k total citations
25 papers, 1.2k citations indexed

About

Luke Gammon is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Luke Gammon has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Molecular Biology and 8 papers in Cell Biology. Recurrent topics in Luke Gammon's work include Cancer Cells and Metastasis (13 papers), Skin and Cellular Biology Research (4 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). Luke Gammon is often cited by papers focused on Cancer Cells and Metastasis (13 papers), Skin and Cellular Biology Research (4 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). Luke Gammon collaborates with scholars based in United Kingdom, Norway and Japan. Luke Gammon's co-authors include Ian C. Mackenzie, Adrian Biddle, Daniela Elena Costea, Bilal Fazil, Kristina Xiao Liang, Lisa J. Harper, Helena Emich, Harshad Navsaria, John A. McGrath and Lu Liu and has published in prestigious journals such as The Lancet, PLoS ONE and Cancer Research.

In The Last Decade

Luke Gammon

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luke Gammon United Kingdom 17 624 574 355 335 96 25 1.2k
Natalia Marchenko United States 17 836 1.3× 681 1.2× 423 1.2× 150 0.4× 65 0.7× 30 1.3k
Kumar Sukhdeo United States 12 969 1.6× 565 1.0× 199 0.6× 255 0.8× 136 1.4× 28 1.5k
Evelyn Susanto Australia 7 623 1.0× 760 1.3× 332 0.9× 183 0.5× 34 0.4× 9 1.3k
Thomas Hussenet France 14 907 1.5× 557 1.0× 333 0.9× 235 0.7× 52 0.5× 16 1.5k
Laurent Fattet United States 18 1.1k 1.7× 673 1.2× 344 1.0× 699 2.1× 72 0.8× 23 2.0k
Sheila Bryson United Kingdom 11 987 1.6× 570 1.0× 181 0.5× 215 0.6× 100 1.0× 16 1.3k
Ana Rita Nobre Portugal 16 647 1.0× 741 1.3× 462 1.3× 222 0.7× 40 0.4× 24 1.4k
Naoki Oshimori United States 13 968 1.6× 461 0.8× 257 0.7× 360 1.1× 39 0.4× 17 1.5k
Adrian Biddle United Kingdom 19 887 1.4× 985 1.7× 557 1.6× 224 0.7× 43 0.4× 27 1.7k
C. Kieu Germany 10 700 1.1× 560 1.0× 262 0.7× 120 0.4× 43 0.4× 10 1.2k

Countries citing papers authored by Luke Gammon

Since Specialization
Citations

This map shows the geographic impact of Luke Gammon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Gammon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Gammon more than expected).

Fields of papers citing papers by Luke Gammon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke Gammon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Gammon. The network helps show where Luke Gammon may publish in the future.

Co-authorship network of co-authors of Luke Gammon

This figure shows the co-authorship network connecting the top 25 collaborators of Luke Gammon. A scholar is included among the top collaborators of Luke Gammon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke Gammon. Luke Gammon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doldan, Patricio, Luke Gammon, Ian C. Mackenzie, et al.. (2025). A CD24+CD271+ melanoma cancer stem cell possesses hybrid characteristics of its single marker counterparts and promotes invasion and therapeutic resistance. BMC Biology. 23(1). 235–235. 1 indexed citations
2.
3.
Gammon, Luke, Joanne Chin‐Aleong, Joanne E. Martin, et al.. (2021). Expression of p16 Within Myenteric Neurons of the Aged Colon: A Potential Marker of Declining Function. Frontiers in Neuroscience. 15. 747067–747067. 19 indexed citations
4.
Huang, Yunying, Hana Jedličková, Ambreen Rehman, et al.. (2021). Oxidative Stress-Mediated YAP Dysregulation Contributes to the Pathogenesis of Pemphigus Vulgaris. Frontiers in Immunology. 12. 649502–649502. 18 indexed citations
5.
Patel, Ankit, Luke Gammon, Tania Maffucci, et al.. (2020). Targeting p63 Upregulation Abrogates Resistance to MAPK Inhibitors in Melanoma. Cancer Research. 80(12). 2676–2688. 18 indexed citations
6.
Gammon, Luke, et al.. (2017). Investigation of the properties of the amoeboid cell, a new cell type in oral cancer. The Lancet. 389. S97–S97. 3 indexed citations
7.
Biddle, Adrian, Luke Gammon, Kristina Xiao Liang, Daniela Elena Costea, & Ian C. Mackenzie. (2016). Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma. EBioMedicine. 4. 138–145. 115 indexed citations
8.
Gammon, Luke & Ian C. Mackenzie. (2015). Roles of hypoxia, stem cells and epithelial–mesenchymal transition in the spread and treatment resistance of head and neck cancer. Journal of Oral Pathology and Medicine. 45(2). 77–82. 32 indexed citations
9.
Shigeishi, Hideo, Adrian Biddle, Luke Gammon, et al.. (2014). Elevation in 5‐FU‐induced apoptosis in Head and Neck Cancer Stem Cells by a combination of CDHP and GSK3β inhibitors. Journal of Oral Pathology and Medicine. 44(3). 201–207. 18 indexed citations
10.
Gammon, Luke, Adrian Biddle, Hannah K. Heywood, Anne Christine Johannessen, & Ian C. Mackenzie. (2013). Sub-Sets of Cancer Stem Cells Differ Intrinsically in Their Patterns of Oxygen Metabolism. PLoS ONE. 8(4). e62493–e62493. 68 indexed citations
11.
Shigeishi, Hideo, Adrian Biddle, Luke Gammon, et al.. (2013). Maintenance of stem cell self-renewal in head and neck cancers requires actions of GSK3β influenced by CD44 and RHAMM. Stem Cells. 31(10). 2073–2083. 59 indexed citations
12.
13.
Gammon, Luke, et al.. (2012). Desmoglein 3 acting as an upstream regulator of Rho GTPases, Rac-1/Cdc42 in the regulation of actin organisation and dynamics. Experimental Cell Research. 318(18). 2269–2283. 36 indexed citations
14.
Biddle, Adrian, Kristina Xiao Liang, Luke Gammon, et al.. (2011). Cancer Stem Cells in Squamous Cell Carcinoma Switch between Two Distinct Phenotypes That Are Preferentially Migratory or Proliferative. Cancer Research. 71(15). 5317–5326. 289 indexed citations
15.
Gammon, Luke, Adrian Biddle, Bilal Fazil, Lisa J. Harper, & Ian C. Mackenzie. (2010). Stem cell characteristics of cell sub-populations in cell lines derived from head and neck cancers of Fanconi anemia patients. Journal of Oral Pathology and Medicine. 40(2). 143–152. 8 indexed citations
16.
Harper, Lisa J., Daniela Elena Costea, Luke Gammon, et al.. (2010). Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance. BMC Cancer. 10(1). 166–166. 86 indexed citations
17.
Chamcheu, Jean Christopher, Elizabeth Pavez Loriè, Baki Akgũl, et al.. (2009). Characterization of immortalized human epidermolysis bullosa simplex (KRT5) cell lines: Trimethylamine N-oxide protects the keratin cytoskeleton against disruptive stress condition. Journal of Dermatological Science. 53(3). 198–206. 31 indexed citations
18.
Costea, Daniela Elena, et al.. (2008). Epithelial stem cells and malignancy. Journal of Anatomy. 213(1). 45–51. 5 indexed citations
19.
Gammon, Luke, Lu Liu, Jemima E. Mellerio, et al.. (2008). Potential of Fibroblast Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa. Journal of Investigative Dermatology. 128(9). 2179–2189. 173 indexed citations
20.
Wong, Tak‐Wah, Luke Gammon, Linda Ozoemena, et al.. (2007). A single intradermal injection of allogenic fibroblasts can increase type VII collagen expression in recessive dystrophic epidermolysis bullosa for a least 3 months.. Journal of Investigative Dermatology. 127. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalia Marchenko Breakdown of academic impact, for papers by Kumar Sukhdeo Breakdown of academic impact, for papers by Evelyn Susanto Breakdown of academic impact, for papers by Thomas Hussenet Breakdown of academic impact, for papers by Laurent Fattet Breakdown of academic impact, for papers by Sheila Bryson Breakdown of academic impact, for papers by Ana Rita Nobre Breakdown of academic impact, for papers by Naoki Oshimori Breakdown of academic impact, for papers by Adrian Biddle Breakdown of academic impact, for papers by C. Kieu
Rankless by CCL
2026